Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are the first choice for the treatment of acute myocardial infarction (AMI), and angiotensin receptor blockers (ARBs) should be considered in patients intolerant to ACEIs. Although previous studies support the use of ARBs as an alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sungmin, Choo, Eun Ho, Choi, Ik Jun, Ihm, Sang-Hyun, Kim, Hee-Yeol, Ahn, Youngkeun, Chang, Kiyuk, Jeong, Myung Ho, Seung, Ki-Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875434/
https://www.ncbi.nlm.nih.gov/pubmed/31760711
http://dx.doi.org/10.3346/jkms.2019.34.e289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875434/
https://www.ncbi.nlm.nih.gov/pubmed/31760711
http://dx.doi.org/10.3346/jkms.2019.34.e289

Ejemplares similares